College students ages 18-24 are at increased risk for
serogroup B meningococcal disease when compared with non-college students, and
while the incidence is low, the illness is serious and potentially deadly,
according to a study published in the January 2019 issue of Pediatrics.
The study, “Meningococcal Disease Among College-aged Young Adults: 2014-2016”
(published Dec. 31 online), analyzed data from the National Notifiable Diseases
Surveillance System and enhanced meningococcal disease surveillance. From 2014
to 2016, 166 cases of meningococcal disease were reported in people ages 18-24,
including 83 who were college students, the study reports. Within the group of
college students, 60 (76.9 percent) of the cases were due to serogroup B,
compared with 28 (38.4 percent) of non-college students, with a 3.54-fold risk
for serogroup B meningococcal disease among college students compared to
non-college students. The vaccine for serogroup B (MenB) is not routinely
recommended for all adolescents or college students but is available based on
clinical decision-making. Students entering college and planning to live in
dorms have also historically been at a higher risk than other people of the
same age for meningococcal serogroup C and Y infections and are routinely recommended
to receive the quadrivalent meningococcal conjugate (MenACWY) vaccine.
Researchers suggest boosting awareness among parents and providers about the
availability of MenB vaccine, given the new information about the increased
risk among college students for sporadic or outbreak-associated serogroup B
meningococcal disease, and ensuring that students are up to date on the MenACWY
Editor’s Note: A solicited commentary, “Increased Risk ofMenB Infection in College Students: Time to Reconsider Vaccine Recommendations,” will be published in the same issue of Pediatrics.
The American Academy of Pediatrics is an organization of 67,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists dedicated to the health, safety and well-being of infants, children, adolescents and young adults. For more information, visit www.aap.org and follow us on Twitter @AmerAcadPeds